ImmunologybioRxiv
Peptides derived of kunitz-type serine protease inhibitor as potential vaccine against experimental schistosomiasis
J. Hernandez-Goenaga, J. Lopez-Aban, A. V. Protasio…·A. Muro
This study evaluates the protective efficacy of peptides derived from a kunitz-type serine protease inhibitor in a vaccine against schistosomiasis, showing significant reductions in parasite recovery and organ damage in vaccinated mice.
DOI 10.3389/fimmu.2019.02498